We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $5.89B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
-17.15%
1 Year Est. Return
+28.74%
3 Year Est. Return
+88.57%
5 Year Est. Return
+106.57%
10 Year Est. Return
+590.49%
AUM
$8.39B
AUM Growth
-$2.83B
Cap. Flow
-$558M
Cap. Flow %
-6.65%
Top 10 Hldgs %
14.4%
Holding
248
New
31
Increased
82
Reduced
108
Closed
26

Top Buys

Rank Stock Value
1
RNR icon
RenaissanceRe
RNR
+$141M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$61.4M
3
COR icon
Cencora
COR
+$54.7M
4
TWLO icon
Twilio
TWLO
+$48.8M
5
SNPS icon
Synopsys
SNPS
+$47.3M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$80.7M
2
HXL icon
Hexcel
HXL
+$75.2M
3
CPAY icon
Corpay
CPAY
+$67.7M
4
NUVA
NuVasive, Inc.
NUVA
+$66.2M
5
DLB icon
Dolby
DLB
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 27.72%
2 Healthcare 17.67%
3 Industrials 16.97%
4 Financials 9.79%
5 Consumer Discretionary 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNR icon
1
RenaissanceRe
RNR
$13.8B
$170M 2.03%
1,140,700
+794,250
+229% +$141M
PGR icon
2
Progressive
PGR
$128B
$148M 1.77%
2,008,250
-167,700
-8% -$12.9M
BAH icon
3
Booz Allen Hamilton
BAH
$8.44B
$132M 1.58%
1,928,305
-508,865
-21% -$37.5M
SBAC icon
4
SBA Communications
SBAC
$19.8B
$123M 1.46%
453,787
+38,747
+9% +$10.2M
ZNGA
5
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$110M 1.31%
16,084,600
+1,328,650
+9% +$8.73M
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$123B
$110M 1.31%
460,340
-21,530
-4% -$4.94M
CBRE icon
7
CBRE Group
CBRE
$43.3B
$108M 1.29%
2,876,100
-484,320
-14% -$26.8M
GPN icon
8
Global Payments
GPN
$24.1B
$108M 1.29%
751,075
-441,715
-37% -$80.7M
TRU icon
9
TransUnion
TRU
$16B
$105M 1.25%
1,582,975
-696,505
-31% -$60.2M
CRL icon
10
Charles River Laboratories
CRL
$11.3B
$92.6M 1.1%
733,850
-59,925
-8% -$8.99M
AVLR
11
DELISTED
Avalara, Inc.
AVLR
$92.3M 1.1%
1,237,865
-322,805
-21% -$26.3M
PCTY icon
12
Paylocity
PCTY
$7.75B
$90.9M 1.08%
1,029,520
-236,480
-19% -$29.7M
XLRN
13
DELISTED
Acceleron Pharma
XLRN
$89.8M 1.07%
999,320
-126,255
-11% -$9.81M
EHC icon
14
Encompass Health
EHC
$11.3B
$89.3M 1.06%
1,752,572
+721,591
+70% +$41.6M
CNC icon
15
Centene
CNC
$30.5B
$88.7M 1.06%
1,493,790
+125,640
+9% +$7.62M
WCN
16
Waste Connections
WCN
$43.6B
$86.1M 1.03%
1,111,100
-106,100
-9% -$9.97M
LFUS icon
17
Littelfuse
LFUS
$10.4B
$84.9M 1.01%
636,315
+69,815
+12% +$11.7M
TYL icon
18
Tyler Technologies
TYL
$13.7B
$83.3M 0.99%
280,975
+1,085
+0.4% +$336K
CHE icon
19
Chemed
CHE
$7.16B
$82.2M 0.98%
189,765
+21,525
+13% +$9.61M
IT icon
20
Gartner
IT
$11.1B
$81.9M 0.98%
822,200
+210,000
+34% +$28.8M
CTLT
21
DELISTED
CATALENT, INC.
CTLT
$79.5M 0.95%
1,529,575
+29,015
+2% +$1.58M
QTWO icon
22
Q2 Holdings
QTWO
$3.78B
$79.3M 0.95%
1,342,593
+137,870
+11% +$10.7M
ZD icon
23
Ziff Davis
ZD
$2B
$78.3M 0.93%
1,202,555
-207,161
-15% -$16.2M
MRVL icon
24
Marvell Technology
MRVL
$147B
$77.4M 0.92%
3,420,000
-283,251
-8% -$6.79M
RPM icon
25
RPM International
RPM
$13.8B
$77M 0.92%
1,294,105
-148,495
-10% -$10.2M
1
2 3 4 5

Similar funds

VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $5.87B AUM 24.95% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return

TimesSquare Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, TimesSquare Capital Management held 248 positions worth $8.39B, down 25% from $11.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

TimesSquare Capital Management withdrew a net $558M in Q1 2020, closing 26 positions and reducing 108 holdings. Its most notable exit was Hexcel, an estimated $75.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in Alexion Pharmaceuticals worth $56.2M.

  • TimesSquare Capital Management's largest Q1 2020 buy was Alexion Pharmaceuticals: 625,500 shares worth $56.2M.
  • TimesSquare Capital Management added most to RenaissanceRe in Q1 2020, an estimated $141M increase.
  • TimesSquare Capital Management's biggest Q1 2020 reduction was Global Payments, cutting an estimated $80.7M.
  • TimesSquare Capital Management fully exited Hexcel in Q1 2020, selling an estimated $75.2M.
  • TimesSquare Capital Management's ten largest holdings make up 14% of its $8.39B portfolio in Q1 2020.
  • TimesSquare Capital Management opened 31 new positions and closed 26 in Q1 2020.
  • TimesSquare Capital Management's portfolio value fell 25% quarter-over-quarter to $8.39B.

Based on TimesSquare Capital Management's 13F filing for Q1 2020, filed 8 May 2020.